Abstract: Disclosed is an intravenous drug dispensing kit including: a cylinder cartridge for introducing and discharging external fluids through changes in the volume of a cylinder occurring when a pair of first and second pistons disposed therein is fixed and rotates relatively to each other; a first tube connected to an outlet tube of the cylinder cartridge; a three-way valve having a first introducing flow path, a second introducing flow path, and a discharge flow path connected to any one of the first introducing flow path and the second introducing flow path; a second tube for connecting the discharge flow path of the three-way valve to an inlet tube of the cylinder cartridge; a third tube connected to the first introducing flow path of the three-way valve; and a fourth tube connected to the second introducing flow path of the three-way valve.

Abstract: A composition suitable for diagnosing a musculoskeletal disease and a composition suitable for preventing or treating a musculoskeletal disease are disclosed. The composition contains zinc finger protein with KRAB and SCAN domains 8 (Zkscan8) protein, which can be effectively used as an excellent biomarker for obtaining accurate information about the occurrence and progression stages of a musculoskeletal disease, specifically a tendon disease or a ligament disease. The compositions containing Zkscan8 can be effectively used for preventing or treating a musculoskeletal disease through Zkscan8 overexpression.

Abstract: A semiconductor package includes an insulating layer including a first face and a second face opposite each other, a redistribution pattern including a wiring region and a via region in the insulating layer, the wiring region being on the via region, and a first semiconductor chip connected to the redistribution pattern. The first semiconductor chip may be on the redistribution pattern. An upper face of the wiring region may be coplanar with the first face of the insulating layer.

Abstract: The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3).

Abstract: A semiconductor device includes a substrate, a gate electrode on the substrate, a gate spacer on a sidewall of the gate electrode, an active pattern penetrating the gate electrode and the gate spacer, and an epitaxial pattern contacting the active pattern and the gate spacer. The gate electrode extends in a first direction. The gate spacer includes a semiconductor material layer. The active pattern extends in a second direction crossing the first direction.

Abstract: The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent device with improved driving voltage and/or power efficiency can be provided by using the organic electroluminescent compound according to the present disclosure.

Abstract: Exemplary methods of treating a chamber may include delivering a cleaning precursor to a remote plasma unit. The methods may include forming a plasma of the cleaning precursor. The methods may include delivering plasma effluents of the cleaning precursor to a processing region of a semiconductor processing chamber. The processing region may be defined by one or more chamber components. The one or more chamber components may include an oxide coating. The methods may include halting delivery of the plasma effluents. The methods may include treating the oxide coating with a hydrogen-containing material delivered to the processing region subsequent halting delivery of the plasma effluents.

Abstract: This application relates to a composition for preventing, treating, and improving skeletal muscle atrophy, the composition including an organoselenium compound. The composition recovered the thickness of muscle fiber reduced by dexamethasone treatment. In addition, the treatment of mice in a muscle loss model showed that the composition had an effect of reducing damaged muscle and of restoring muscle mass. Therefore, it is expected that the composition can be effectively used for the treatment, prevention, or improvement of muscle atrophy.

Abstract: An apparatus for estimating blood pressure includes: a sensor, and a processor configured to estimate blood pressure based on a PPG signal and a contact pressure signal measured by the sensor. The sensor includes: a transparent elastic body; a first polarizing film provided on a surface of the transparent elastic body and configured to come into contact with the object; a light source provided under the transparent elastic body and configured to emit light toward the object; a first detector and a second detector provided under the transparent elastic body and configured to detect light, passing through the first polarizing film after being emitted by the light source and scattered or reflected from the object, to measure the PPG signal; and a second detector provided under the transparent elastic body and configured to detect light, not passing through the first polarizing film, to measure the contact pressure signal.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating small cell lung cancer associated with a RON mutation and a method using the same. The compound according to the present invention may be usefully used as a precision medicine in the treatment of a patient with small cell lung cancer which has resistance to an EGFR-targeted therapeutic agent used in conventional anticancer therapy and has the RON?155, RON?160, and RON?165 mutations.

Abstract: An organic light emitting diode display device includes a substrate having a plurality of subpixels; and an emitting material layer in the plurality of subpixels on the substrate, wherein the emitting material layer in at least one of the plurality of subpixels comprises: a first emitting material layer including a first host and a dopant; a second emitting material layer on the first emitting material layer and including a second host and the dopant; and a third emitting material layer on the second emitting material layer and including one of the dopant and the second host.

Abstract: The present disclosure provides a device for carrying out magnetic resonance imaging compatible optogenetics; and methods for using the device.

Abstract: The carrier-foil-attached ultra-thin copper foil according to one embodiment of the present invention comprises a carrier foil, a release layer, a first ultra-thin copper foil, a Cu—Al bonding strength improvement layer, an Al layer, and a second ultra-thin copper foil, wherein the release layer may comprise a first metal (A3) having peeling properties, and a second metal (B3) and third metal (C3) facilitating the plating of the first metal (A3).

Abstract: A display device includes a display panel having flexibility, a storage connected to a first end of the display panel and accommodating the display panel so that the display panel is inserted and withdrawn, an extension part connected to a second end of the display panel, which is opposite to the first end of the display panel, and facing one side of the storage in a first direction, and a display driving integrated circuit which receives image data and a control signal from a host and provides a data signal to the display panel. The display driving integrated circuit includes a data processor which receives a smart size change signal from the host and sets a non-active area of the display panel based on the smart size change signal.

Abstract: A lithium secondary battery includes an electrode assembly including a cathode and an anode facing the cathode, a case accommodating the electrode assembly, an electrolyte accommodated in the case together with the electrode assembly, and an electrolyte storage unit inserted into the case to supply a supplementary replenishment. The electrolyte storage unit includes a first unit including a first body having a tubular structure and first holes formed through the first body, and a sub-unit including a tubular body and sub-holes formed through the tubular body. The sub-unit is inserted into the first unit so that the sub-holes are offset from the first holes.

Abstract: A random access method for a terminal with the processor and the memory to access a low earth orbit satellite network formed by multiple low earth orbit satellites (LE0 SAT) includes: the stage where a Deep Reinforcement Learning (DRL) algorithm is applied for a pre-set time to decide which one between the first and the second actions should be performed at every access cycle, and to perform the random access to the low earth orbit satellite network based on the above decision while learning it; and the stage where, according to the learning result of the DRL algorithm performed for above pre-set time, it decides which of the first and the second actions should be chosen when attempting to access the low earth orbit satellite network at a new access cycle and then to perform the random access to the low earth orbit satellite network according to the above choice.

Abstract: An HVAC system including a sterilization unit is provided, wherein in one embodiment the sterilization unit is located within the HVAC system. The sterilization unit includes a housing configured to envelop an outer side surface of the sterilization unit, an irradiation unit located on one side surface of the housing, and reflection units located in the housing so as to face the irradiation unit.

Abstract: A member for a metal oxide nanofiber based gas sensor can include a metal nanoparticle catalyst and can be formed to be functionalized by binding the metal nanoparticle catalyst and an alkali or alkaline earth metal through electrospinning and heat treatment processes. The member can detect a trace amount of a gas with high selectivity and ultra-high sensitivity by uniformly binding the alkali or alkaline earth metal and the metal nanoparticle catalyst through electrospinning and high-temperature heat treatment.

Abstract: A system and method is provided for modeling brain dynamics in normal and diseased states.

Abstract: The present invention is directed to novel heterodimeric antibodies.